High-grade dysplasia associated with fundic gland polyposis in a familial adenomatous polyposis patient, with special reference to APC mutation profiles

Modern Pathology

Volumn 17, Issue 11, 2004, Pages 1421-1426

  Sekine, Shigeki ^a   Shimoda, Tadakazu ^b   Nimura, Satoshi ^b   Nakanishi, Yukihiro ^a   Akasu, Takayuki ^c   Katai, Hitoshi ^c   Gotoda, Takuji ^d   Shibata, Tatsuhiro ^a   Sakamoto, Michiie ^a,e   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Clinical Laboratory Division   (Japan)

^c Department of Surgery ^*

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

APC; Familial adenomatous polyposis; Gastric dysplasia

Indexed keywords

ADENOMATOUS POLYP; ADULT; ARTICLE; CASE REPORT; CODON; GENE DELETION; GENE INACTIVATION; GENE INSERTION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; MALE; POLYPOSIS; PRIORITY JOURNAL; STOMACH PARIETAL CELL; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; ADULT; BASE SEQUENCE; GASTRIC FUNDUS; GENES, APC; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYPS;

EID: 8344255014     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800178     Document Type: Article

References (24)

1. Iida M, Yao T, Itoh H, et al. Natural history of fundic gland polyposis in patients with familial adenomatosis coli/Gardner's syndrome. Gastroenterology 1985;89:1021-1025.
2. Sarre RG, Frost AG, Jagelman DG, et al. Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps. Gut 1987;28:306-314.
3. Domizio P, Talbot IC, Spigelman AD, et al. Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients. J Clin Pathol 1990;43:738-743.
4. Toyooka M, Konishi M, Kikuchi-Yanoshita R, et al. Somatic mutations of the adenomatous polyposis coli gene in gastroduodenal tumors from patients with familial adenomatous polyposis. Cancer Res 1995;55:3165-3170.
5. Abraham SC, Nobukawa B, Giardiello FM, et al. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol 2000;157:747-754.
6. Wu TT, Kornacki S, Rashid A, et al. Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol 1998;22:293-298.
7. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-255.
8. Sekine S, Shibata T, Yamauchi Y, et al. β-Catenin mutations in sporadic fundic gland polyps. Virchows Arch 2002;440:381-386.
9. Coffey Jr RJ, Knight Jr CD, van Heerden JA, et al. Gastric adenocarcinoma complicating Gardner's syndrome in a North American woman. Gastroenterology 1985;88:1263-1266.
10. Odze RD, Quinn PS, Terrault NA, et al. Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis. Hum Pathol 1993;24:442-448.
11. Zwick A, Munir M, Ryan CK, et al. Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology 1997;113:659-663.
12. Hofgartner WT, Thorp M, Ramus MW, et al. Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol 1999;94:2275-2281.
13. Attard TM, Giardiello FM, Argani P, et al. Fundic gland polyposis with high-grade dysplasia in a child with attenuated familial adenomatous polyposis and familial gastric cancer. J Pediatr Gastroenterol Nutr 2001;32:215-218.
14. Laken SJ, Papadopoulos N, Petersen GM, et al. Analysis of masked mutations in familial adenomatous polyposis. Proc Natl Acad Sci USA 1999;96:2322-2326.
15. Abraham SC, Nobukawa B, Giardiello FM, et al. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the β-catenin gene. Am J Pathol 2001;158:1005-1010.
16. Abraham SC, Park SJ, Mugartegui L, et al. Sporadic fundic gland polyps with epithelial dysplasia: evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Pathol 2002;161:1735-1742.
17. Sparks AB, Morin PJ, Vogelstein B, et al. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998;15;58:1130-1134.
18. Henderson BR. Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover. Nat Cell Biol 2000;2:653-660.
19. Kielman MF, Rindapaa M, Gaspar C, et al. APC modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling. Nat Genet 2002;32:594-605.
20. Rosin-Arbesfeld R, Cliffe A, Brabletz T, et al. Nuclear export of the APC tumour suppressor controls β-catenin function in transcription. EMBO J 2003;22:1101-1113.
21. Albuquerque C, Breukel C, van der Luijt R, et al. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade. Hum Mol Genet 2002;11:1549-1560.
22. Rowan AJ, Lamlum H, Ilyas M, et al. APC mutations in sporadic colorectal tumors: a mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci USA 2000;97:3352-3357.
23. Lamlum H, Ilyas M, Rowan A, et al. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med 1999;5:1071-1075.
24. Groves C, Lamlum H, Crabtree M, et al. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 2002;160:2055-2061.